University Hospitals Plymouth NHS Trust, Derriford Hospital
Welcome,         Profile    Billing    Logout  
 7 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jackson, Robert M
NCT05671835: Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting
2
75
US
TTI-101, Placebo
Tvardi Therapeutics, Incorporated
Idiopathic Pulmonary Fibrosis
03/25
07/25
NCT05962606: Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

Recruiting
2
150
Europe
AON-D21, Placebo
Aptarion Biotech AG
Community-acquired Pneumonia
05/26
06/26
NCT05571059: Oral Ifetroban in Patients with Idiopathic Pulmonary Fibrosis (IPF)

Recruiting
2
128
US
Ifetroban Sodium, ifetroban, Placebo
Cumberland Pharmaceuticals
Idiopathic Pulmonary Fibrosis
01/26
01/26
TLIF, NCT04073563: Transforaminal Lumbar Interbody Fusion

Recruiting
N/A
1017
US, RoW
Infuse™ Bone Graft (Infuse™), Intervertebral body fusion device and Medtronic posterior Fixation Systems
Medtronic Spinal and Biologics
Degenerative Disease of the Lumbosacral Spine
04/26
04/28
Hobart, Jeremy
ChariotMS, NCT04695080 / 2018-005038-39: - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

Recruiting
2/3
200
Europe
Cladribine (MAVENCLAD®), Placebo
Queen Mary University of London, National Institute for Health Research, United Kingdom, Merck Serono Limited, UK, Multiple Sclerosis Society of Great Britain & Northern Ireland, National Multiple Sclerosis Society, Barts & The London NHS Trust
Advanced Multiple Sclerosis, Progressive Multiple Sclerosis
12/24
12/27
Froud, Julie
No trials found
Hurley, Jennifer
No trials found
Redmond-Harrison, Henry
No trials found

Download Options